Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJan 18, 2023Rifampin Capsules USPFailed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.Lupin Pharmaceuticals Inc. · D-0100-2023Class IITerminatedJan 18, 2023Rocuronium Bromide InjectionLack of Assurance of SterilityNephron Sterile Compounding Center LLC · D-0099-2023Class IITerminatedJan 18, 2023Rifampin CapsulesFailed Impurities/Degradation specificationsRemedyRepack Inc. · D-0098-2023Class IITerminatedJan 11, 2023Epi-CaineCGMP Deviations: Raw material recalled by repackager, due to discoloration.Pine Pharmaceuticals, LLC · D-0130-2023Class IICompletedJan 11, 2023Heparin Sodium 2Lack of assurance of sterility: Bags have the potential to leak.Pfizer Inc. · D-0097-2023Class IIITerminatedJan 11, 2023Prochlorperazine Maleate TabletsSubpotent Drug: Out of specification for assay at the 18-month stability timepoint.Jubilant Cadista Pharmaceuticals, Inc. · D-0096-2023Class IIOngoingJan 11, 2023Acyclovir Sodium Injection 1Presence of Particulate Matter: Customer complaint of dark particles found inside the vialEugia US LLC · D-0095-2023Class IIITerminatedJan 4, 2023Timolol Maleate Ophthalmic SolutionFailed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.Apotex Corp. · D-0093-2023Class IICompletedJan 4, 2023Alcohol Antiseptic 80% Topical Solution Hand SanitizerCGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.NCH Life Sciences LLC · D-0092-2023Class IICompletedJan 4, 2023Glycopyrrolate TabletsFailed impurities/degradation specifications: Out of specification for unknown impurities.Avkare LLC · D-0091-2023Class IITerminatedJan 4, 2023Ganciclovir for InjectionLabeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.Hikma Pharmaceuticals USA Inc. · D-0090-2023Class IITerminatedDec 28, 2022Quinapril Tablets USPCGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.Lupin Pharmaceuticals Inc. · D-0089-2023Class IITerminatedDec 28, 2022Quinapril Tablets USPCGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.Lupin Pharmaceuticals Inc. · D-0088-2023Class IIOngoingDec 28, 2022Glycopyrrolate TabletsFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-0087-2023Class IITerminatedDec 28, 2022Oxcarbazepine Tablets 600mgPresence of foreign substanceSun Pharmaceutical Industries Inc · D-0085-2023Class IIITerminatedDec 21, 2022Lacosamide Oral SolutionFailed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid contentCamber Pharmaceuticals, Inc · D-0094-2023Class ITerminatedDec 21, 2022IohexolLabeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mLBayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy · D-0086-2023Class IITerminatedDec 21, 2022MenastilcGMP DeviationsAtlantic Management Resources Ltd. · D-0084-2023Class IITerminatedDec 21, 2022ProSironacGMP DeviationsAtlantic Management Resources Ltd. · D-0083-2023Class IITerminatedDec 21, 2022NeuroquellcGMP DeviationsAtlantic Management Resources Ltd. · D-0082-2023Class IITerminatedDec 21, 2022Neuroquell PluscGMP DeviationsAtlantic Management Resources Ltd. · D-0081-2023Class ITerminatedDec 21, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.Exela Pharma Sciences LLC · D-0080-2023Class ITerminatedDec 21, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.Exela Pharma Sciences LLC · D-0079-2023Class IITerminatedDec 21, 2022FentaNYL Citrate 2.5 mg/50 mLUnderfilled units.OurPharma LLC · D-0078-2023Class IITerminatedDec 14, 2022Desmopressin Acetate TabletSubpotent Drug: repackaged product was recalled by the manufacturer for subpotency.RemedyRepack Inc. · D-0077-2023Class IITerminatedDec 14, 20220.9% Sodium Chloride Injection USP 1000 mL Single-dose containerLack of sterility assurance: Bags have the potential to leak.B. Braun Medical, Inc. · D-0076-2023Class IIOngoingDec 14, 20220.9% Sodium Chloride InjectionLack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.Fresenius Medical Care Holdings, Inc. · D-0075-2023Class IIITerminatedDec 7, 2022Sodium Sulfacetamide 10% Sulfur 4% Cleansing PadsSubpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.Acella Pharmaceuticals, LLC · D-0074-2023Class IIITerminatedDec 7, 2022Allergy Relief DFailed dissolution specificationsDr. Reddy's Laboratories, Inc. · D-0073-2023Class IITerminatedDec 7, 2022Desmopressin Acetate Tablets 0.2mgSubpotent DrugHeritage Pharmaceuticals Inc · D-0072-2023Class IIOngoingDec 7, 2022DaytranaDefective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal...Noven Pharmaceuticals Inc · D-0071-2023Class IIITerminatedNov 30, 2022Phenytoin Sodium InjectionLabeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.Acella Pharmaceuticals, LLC · D-0070-2023Class IIITerminatedNov 30, 2022Phenytoin Sodium InjectionLabeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.Acella Pharmaceuticals, LLC · D-0069-2023Class IITerminatedNov 30, 2022Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only...DiscolorationSun Pharmaceutical Industries Inc · D-0068-2023Class IIOngoingNov 23, 2022Adam's Polishes ALCOHOL BASED HAND SANITIZERCGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.Adam's Polishes LLC · D-0067-2023Class IOngoingNov 23, 2022Adam's Polishes ALCOHOL BASED HAND SANITIZERChemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL BASED HAND SANITIZER isopropyl alcohol 75% v/v to contain methanol.Adam's Polishes LLC · D-0066-2023Class IITerminatedNov 23, 2022PF-Neostigmine Methylsulfate InjectionCGMP Deviations: Potential for cross contamination due to product carry over.Nephron Sterile Compounding Center LLC · D-0065-2023Class IITerminatedNov 23, 2022PF-Labetalol HCl InjectionCGMP Deviations: Potential for cross contamination due to product carry over.Nephron Sterile Compounding Center LLC · D-0064-2023Class IITerminatedNov 23, 2022Carvedilol TabletsFailed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.Viatris Inc · D-0063-2023Class IIOngoingNov 23, 20220.9% Sodium Chloride InjectionLack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.ICU Medical Inc · D-0062-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.